Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using ...

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...

Key market opportunities in liquid biopsy for early cancer detection include increasing demand for non-invasive diagnosis, ...

The genome testing market offers opportunities in next-generation sequencing, clinical applications, and personalized ...

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

The ₹15,512 crore Tata Capital IPO, open for subscription until October 8, is priced in the range of ₹310– ₹326 per share.

Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...

The allotment status for the highly anticipated Tata Capital IPO is finalized. Investors will be able to check their ...

Deutsche Lufthansa AG plans to start making rapid COVID-19 antigen tests available to passengers in October and is weighing the option of opening test centres at airports in the United States and ...

Bioanalytical testing market driven by rising biologics, gene therapies, and strict regulations, with growing demand for integrated hybrid assay platforms. BRENTFORD, ENGLAND, UNITED KINGDOM, October ...

Overview of the process of obtaining genomic diversity of influenza virus in a population replicated from a single particle. (a) MDCK cells were infected with influenza vi ...

Public-sector banks (PSBs) are attracting the attention of investors and the PSU Bank Index has gained nearly 10 per cent in ...